FDA Commissioner Crawford Fills Top Agency Posts With Familiar Faces
This article was originally published in The Pink Sheet Daily
Former McClellan advisor Gottlieb returns to FDA as a deputy commissioner; Woodcock, Lumpkin, Galson earn permanent appointments to their previous "acting" positions.
You may also be interested in...
Deputy Commissioner for Policy Amit Sachdev is vacating one of three deputy commissioner posts created following the departure of Commissioner McClellan in 2004. Acting Commissioner Crawford’s confirmation to the permanent post could create an opportunity to again reorganize the agency’s leadership structure.
Italy claims to have pushed farther into managed entry agreements than other European countries with strong clawback provisions on new drugs – particularly cancer drugs – if they don't work as well as their manufacturers claim. The financial clawbacks are supported by extensive outcome data collection across the country's twenty regions.
The U.K.’s Health and Social Care Bill was introduced into Parliament on Jan. 19, offering a new commercial landscape best navigated by pharma through bolstered relationships with general practitioners.